Surgical Sutures Market to Reach USD 7,923.8 million by 2032, Growing At An 6.92% CAGR - Credence Research

PUNE, India, Oct. 29, 2025 /PRNewswire/ -- A new in-depth report from Credence Research indicates that the Global Surgical Sutures Market continues its trajectory of robust growth, underpinned by its foundational role in nearly every surgical procedure performed worldwide. The market size, valued at USD 3,251.3 million in 2018, grew steadily to USD 4,659.6 million in 2024. This expansion is set to continue, with the market projected to reach USD 7,923.8 million by 2032, advancing at a compound annual growth rate (CAGR) of 6.92% during the forecast period from 2025 to 2032.

This consistent growth is fueled by a confluence of powerful global trends, including an aging population, the rising prevalence of chronic diseases requiring surgical intervention, and continuous technological advancements in suture materials and designs. As the number of surgical procedures—from complex cardiac operations to routine outpatient surgeries—increases globally, the demand for reliable, high-quality wound closure devices remains perpetually strong. Innovations such as antimicrobial coatings and knotless barbed sutures are further driving market value by improving surgical outcomes and efficiency.

Browse bthe report and understand how it can benefit your business strategy - https://www.credenceresearch.com/report/surgical-sutures-market

Market Overview

The Surgical Sutures Market comprises one of the most fundamental and widely used categories of medical devices. A surgical suture is a thread used to hold body tissues together after an injury or surgery, facilitating the natural healing process. Its primary functions are to approximate wound edges, provide mechanical support to the tissue as it heals, and ligate (tie off) blood vessels. Despite the advent of alternative wound closure methods, sutures remain the gold standard for a vast majority of procedures due to their versatility, strength, and predictable performance.

The market's steady growth, as reflected in its climb to USD 4,659.6 million in 2024 and its projected path to nearly USD 8 billion by 2032, is a direct indicator of the increasing volume of surgical interventions worldwide. This includes a rise in surgeries related to cardiovascular diseases, cancer treatment, orthopedic procedures like joint replacements, and a growing number of cosmetic and plastic surgeries.

The market is broadly segmented by product type into absorbable and non-absorbable sutures. Absorbable sutures are made from materials that are designed to be broken down and absorbed by the body over time through enzymatic reactions or hydrolysis. They are ideal for closing internal tissue layers where suture removal is not feasible or desired. This category includes natural materials like catgut and, more commonly, synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), and polydioxanone (PDS), which offer more predictable absorption rates and less tissue reactivity.

Non-absorbable sutures are made from materials that resist enzymatic degradation and remain permanently in the tissue or are removed by a clinician once the wound has healed sufficiently. They are used in applications requiring long-term mechanical support, such as vascular anastomoses in cardiovascular surgery, or for skin closure. Common materials include natural silk and synthetic polymers like nylon, polypropylene, and polyester. The choice between absorbable and non-absorbable sutures, as well as the specific material and diameter, is a critical clinical decision based on the tissue type, the required strength, and the desired healing time.

Key Growth Determinants

• Increasing Volume of Surgical Procedures Globally: A primary driver is the sheer increase in the number of surgeries performed worldwide. This is fueled by an aging global population requiring more age-related procedures (e.g., cataract surgery, joint replacements), the rising prevalence of chronic diseases like cardiovascular disease and cancer that often necessitate surgical intervention, and an increase in traumatic injuries. As healthcare access expands globally, more patients are undergoing surgery, creating a direct and growing demand for the sutures needed to complete these procedures.
• Growing Demand for Advanced and Specialized Sutures: The market's value is increasingly driven by a shift towards advanced sutures that offer benefits beyond simple wound closure. These include sutures with antimicrobial coatings (e.g., triclosan) that help prevent surgical site infections (SSIs), a major cause of post-operative morbidity. Additionally, the growing adoption of knotless "barbed" sutures, which reduce closure times and are ideal for minimally invasive surgery, command a premium price. This demand for value-added, technologically advanced products is a key factor propelling market revenue.
• Improvements in Healthcare Infrastructure in Emerging Markets: Rapidly developing economies across Asia Pacific, Latin America, and Africa are investing heavily in their healthcare infrastructure. As new hospitals and surgical centers are built and access to medical care improves for millions of people, the number of surgical procedures performed in these regions is rising exponentially. This creates a vast, high-growth market for essential surgical supplies like sutures, providing a major growth engine for global manufacturers looking to expand their footprint.

Key Growth Barriers

• Rising Preference for Alternative Wound Closure Methods: The traditional suture market faces significant competition from alternative wound closure technologies. Surgical staplers, for instance, offer faster skin closure for certain procedures. Tissue adhesives (glues) and sealants provide a non-invasive option for superficial wounds and are increasingly used in pediatric and cosmetic applications. Additionally, advanced energy-based vessel sealing devices are replacing the need for ligatures in some surgeries. This diversification of closure methods can limit the growth potential of sutures in specific clinical scenarios.
• Stringent Regulatory Approval Processes: New surgical suture products, especially those incorporating novel materials or active agents like antimicrobial coatings, are subject to rigorous and lengthy regulatory approval processes by bodies like the U.S. FDA and the European Medicines Agency. This requires extensive preclinical and clinical data to prove safety and efficacy, representing a significant investment of time and capital. These stringent requirements can slow the pace of innovation and act as a high barrier to entry for smaller companies.
• Pricing Pressure and Commoditization: In the high-volume segments of the market, particularly for conventional, non-coated sutures, there is intense pricing pressure. Healthcare providers and group purchasing organizations (GPOs) exert significant leverage to reduce costs, leading to the commoditization of standard suture products. This pressure on pricing can squeeze manufacturer profit margins and makes it challenging to compete without a large scale of economy, forcing companies to focus on higher-value specialty sutures to maintain profitability.

Key Market Trends

• Adoption of Knotless (Barbed) Sutures: A major trend transforming surgical practice is the growing use of barbed sutures. These sutures feature small, bidirectional or unidirectional barbs along their length that anchor into the tissue, eliminating the need for surgeons to tie knots. This innovation significantly speeds up wound closure time, which is particularly valuable in long procedures and in minimally invasive surgery where knot-tying is challenging. This efficiency gain and the ability to create a more secure, watertight closure are driving rapid adoption.
• Development of Antimicrobial-Coated Sutures: In the global fight against healthcare-associated infections, a critical trend is the widespread adoption of sutures coated with an antimicrobial agent, most commonly triclosan. These sutures create a zone of inhibition around the suture line that helps to prevent bacterial colonization, a key factor in the development of surgical site infections (SSIs). As hospitals face increasing pressure to reduce SSI rates, the use of antimicrobial sutures is becoming a standard of care for many procedures.
• Emergence of "Smart" and Bioactive Sutures: The future of the market lies in sutures that do more than just provide mechanical support. This forward-looking trend involves the development of "smart sutures" with integrated functionalities. This includes bioactive sutures that can actively promote healing by releasing growth factors or anti-inflammatory drugs directly into the wound. It also includes research into sensor-equipped sutures that can monitor wound temperature, pH, or tension and wirelessly transmit data to an external device, offering a real-time window into the healing process.

Key Opportunities

• Expansion in Minimally Invasive Surgery (MIS): The global shift towards MIS (laparoscopic and robotic surgery) presents a unique and significant opportunity for specialized sutures. While MIS also utilizes alternative closure methods, the challenges of working in confined spaces make knot-tying particularly difficult. This creates high demand for knotless barbed sutures, which dramatically simplify and accelerate internal tissue approximation. Developing suture products and delivery mechanisms specifically designed for the unique ergonomics of MIS is a key growth avenue.
• Growth in Cosmetic and Plastic Surgery: The global cosmetic surgery market is booming, creating a lucrative opportunity for premium suture products. In procedures like facelifts, rhinoplasty, and breast augmentation, the final aesthetic outcome is paramount. This drives strong demand for fine-gauge, low-reactivity sutures that minimize tissue trauma and scarring. Surgeons and patients in this segment are often less price-sensitive and willing to pay for premium products that deliver superior cosmetic results.
• Untapped Potential in the Veterinary Market: The veterinary healthcare market is a rapidly growing and often underserved segment. As pet owners' willingness to spend on advanced medical care for their companion animals increases, so does the demand for high-quality, sterile surgical sutures for veterinary procedures. While some human-grade sutures are used, there is a distinct opportunity for manufacturers to develop and market a dedicated, cost-effective line of sutures specifically designed and packaged for the diverse needs of veterinary surgeons.

Preview the report with a detailed sample and understand how it can benefit your business strategy. Request a free sample today - https://www.credenceresearch.com/report/surgical-sutures-market

Segmentation

By Type

• Dissolvable Sutures
• Non-Dissolvable Sutures

By Application

• Orthopedic Surgeries
• Cardiovascular Surgeries
• Cosmetic Surgeries
• General Surgeries
• Ophthalmic Surgeries
• Gynecological Surgeries
• Neurological Surgeries
• Others

By End User

• Hospitals
• Ambulatory Centers
• Private Clinics

 Based on the Geography:

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• France
• Germany
• Italy
• Spain
• Russia
• Belgium
• Netherlands
• Austria
• Sweden
• Poland
• Denmark
• Switzerland
• Rest of Europe
• Asia Pacific
• China
• Japan
• South Korea
• India
• Australia
• Thailand
• Indonesia
• Vietnam
• Malaysia
• Philippines
• Taiwan
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Peru
• Chile
• Colombia
• Rest of Latin America
• Middle East
• UAE
• KSA
• Israel
• Turkey
• Iran
• Rest of Middle East
• Africa
• Egypt
• Nigeria
• Algeria
• Morocco
• Rest of Africa

Regional Analysis

North America holds the dominant share of the Global Surgical Sutures Market, a position it maintains due to the high volume of surgical procedures, an advanced healthcare system, and high per capita healthcare spending. Favorable reimbursement policies for surgical interventions and the rapid adoption of new and premium-priced technologies, such as antimicrobial and barbed sutures, further bolster the market's value in this region.

Europe stands as the second-largest market, characterized by its well-established national healthcare systems and a strong emphasis on patient safety and clinical outcomes. An aging population ensures a consistently high volume of surgeries. The stringent CE marking process promotes high-quality standards, and countries like Germany, France, and the UK are major contributors to the regional market.

The Asia Pacific region is projected to be the fastest-growing market during the forecast period. This remarkable growth is driven by expanding healthcare infrastructure, rising disposable incomes, and increasing access to surgical care for a massive population in countries like China and India. A growing burden of chronic diseases and an increase in medical tourism are also key factors fueling the demand for surgical sutures across the region.

Credence Research's Competitive Landscape Analysis

The Global Surgical Sutures Market is highly consolidated, with three major players—Ethicon (a subsidiary of Johnson & Johnson), Medtronic plc, and B. Braun Melsungen AG—commanding a significant majority of the global market share. These industry leaders leverage their vast and comprehensive product portfolios, which span all types of absorbable and non-absorbable sutures, coupled with their powerful brand recognition and extensive global sales and distribution networks. Their long-standing relationships with hospitals, surgeons, and group purchasing organizations create a formidable barrier to entry. Competition among these giants and a host of smaller, specialized players focuses on innovation in materials science, the development of value-added features like antimicrobial coatings, and strategic acquisitions to gain access to new technologies or markets.

Key Player Analysis

• Solventum
• Medtronic
• Demetech Corporation
• Endoevolution LLC
• Johnson and Johnson Services, Inc.
• Braun
• Surgical Sutures Private Limited
• Lotus Surgical
• Life Line Sutures
• Orion Sutures

 Recent Industry Developments

• In July 2025, Smith+Nephew introduced the Q-FIX KNOTLESS All-Suture Anchor, designed for soft tissue-to-bone fixation across multiple joints, including the shoulder, hip, and foot & ankle. The innovation enhances surgical efficiency and fixation strength.
• In June 2025, OSSIO, Inc. launched its OSSIOfiber 2.5 mm Suture Anchors, expanding its soft-tissue fixation portfolio. The non-metallic material integrates naturally into bone, minimizing side effects and improving surgical outcomes.
• In January 2025, Medtronic reported total revenue of USD 33.5 billion, with its Medical Surgical Portfolio contributing USD 8.4 billion, driven by steady growth in its LigaSure vessel-sealing line.
• In July 2024, Corza Medical completed the acquisition of TachoSil manufacturing operations in Linz, Austria, integrating it into Takeda's global production network. TachoSil remains a globally recognized surgical patch used for bleeding control and tissue sealing.
• In July 2024, Advanced Medical Solutions (AMS) acquired Peters Surgical, a France-based company known for expertise in sutures, hemostatic clips, and surgical glues. This acquisition strengthens AMS's surgical wound care and closure portfolio.
• In May 2024, KKR acquired Healthium Medtech Ltd., one of India's largest surgical suture manufacturers, from Apax Partners, reinforcing its global presence in the medical device sector.
• In February 2024, Novo Integrated Sciences, along with its subsidiary Clinical Consultants International, partnered with Futura Surgicare to introduce Dolphin sutures and mesh products in the North American market.
• In October 2024, Corza Medical unveiled its Onatec Ophthalmic Microsurgical Sutures at the American Academy of Ophthalmology Conference, marking a key expansion in ophthalmic solutions.
• In September 2024, Meril Life Sciences launched the New Edge Suture, designed for open, laparoscopic, and robotic surgeries, to enhance precision and wound closure strength.
• In August 2023, Riverpoint Medical invested USD 10 million in a new 4,000-square-meter manufacturing facility in the Coyol Free Trade Zone, Costa Rica. The site includes two certified clean rooms for producing absorbable and non-absorbable orthopedic sutures, supporting the region's growth as a medical device hub.

 Reasons to Purchase this Report:

• Gain a comprehensive understanding of the market through qualitative and quantitative analyses, considering both economic and non-economic factors, with segmentation and sub-segmentation details provided in terms of market value (USD Billion).
• Identify regions and segments expected to experience the fastest growth or dominate the market, with a detailed analysis of geographic consumption patterns and the factors driving or hindering market performance in each region.
• Stay informed about the competitive environment, with rankings of major players, recent product and service launches, partnerships, business expansions, and acquisitions from the past five years.
• Access detailed profiles of major market players, including company overviews, insights, product benchmarking, and SWOT analysis, to understand competitive advantages and market positioning.
• Explore the present and forecasted market landscape, with insights into growth opportunities, market drivers, challenges, and constraints for both developed and emerging regions.
• Benefit from Porter's Five Forces analysis and Value Chain insights to evaluate various market perspectives and competitive dynamics.
• Understand the evolving market scenario, including potential growth opportunities and trends expected in the coming years.

Tailor the report to align with your specific business needs and gain targeted insights. Request Here - https://www.credenceresearch.com/report/surgical-sutures-market

Discover additional reports tailored to your industry needs

Surgical Lamp Market https://www.credenceresearch.com/report/surgical-lamps-market
Surgical Navigation Systems Market https://www.credenceresearch.com/report/surgical-navigation-systems-market
Surgical Stapler Market https://www.credenceresearch.com/report/surgical-stapler-market
Wound Closure Surgical Products Market https://www.credenceresearch.com/report/wound-closure-surgical-products-market
Orthopedic Surgical Robots Market https://www.credenceresearch.com/report/orthopedic-surgical-robots-market

Follow Us:
https://www.linkedin.com/company/credenceresearch/
https://x.com/CredenceResearc
https://www.facebook.com/CredenceResearch

About Us:

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 2000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives.

Contact Us

Credence Research Europe LTD
128 City Road, London,
EC1V 2NX, UNITED KINGDOM
Europe - +44 7809 866 263
North America - +1 304 308 1216
Australia - +61 4192 46279
Asia Pacific - +81 5050 50 9250
+64 22 017 0275
India - +91 6232 49 3207
sales@credenceresearch.com
www.credenceresearch.com

Logo: https://mma.prnewswire.com/media/2562161/Credence_Research_Logo.jpg